Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition.
Abou Assi L, Alkhansa S, Njeim R, Ismail J, Madi M, Ghadieh HE, Al Moussawi S, Azar TS, Ayoub M, Azar WS, Hamade S, Nawfal R, Haddad NR, Harb F, Faour W, Khalil MI, Eid AA.
Abou Assi L, et al. Among authors: alkhansa s.
Pharmaceutics. 2024 Jul 19;16(7):955. doi: 10.3390/pharmaceutics16070955.
Pharmaceutics. 2024.
PMID: 39065652
Free PMC article.